Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
Author
| Aman, M. G. | 1 |
| Aman, Michael G. | 1 |
| Arnold, L. E. | 1 |
| Arnold, L. Eugene | 1 |
| Bearss, K. | 1 |
| Chowdhury, M. | 1 |
| Cook, Amelia M. | 1 |
| Hall, Kristy L. | 1 |
| Handen, B. | 1 |
| Johnson, C. | 1 |
| Lecavalier, L. | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Aberrant Behavior Checklist | 2 |
| Vineland Adaptive Behavior… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkChowdhury, M.; Aman, M. G.; Scahill, L.; Swiezy, N.; Arnold, L. E.; Lecavalier, L.; Johnson, C.; Handen, B.; Stigler, K.; Bearss, K.; Sukhodolsky, D.; McDougle, C. J. – Journal of Intellectual Disability Research, 2010
Background: The Home Situations Questionnaire (HSQ) is a caregiver-rated scale designed to assess behavioural non-compliance in everyday settings that has been used in several studies in typically developing children. Currently there is no accepted measure of behavioural non-compliance in children with pervasive developmental disorders (PDDs).…
Descriptors: Autism, Pervasive Developmental Disorders, Factor Structure, Pharmacology
Atomoxetine for Hyperactivity in Autism Spectrum Disorders: Placebo-Controlled Crossover Pilot Trial
Arnold, L. Eugene; Aman, Michael G.; Cook, Amelia M.; Witwer, Andrea N.; Hall, Kristy L.; Thompson, Susan; Ramadan, Yaser – Journal of the American Academy of Child and Adolescent Psychiatry, 2006
Objective: To explore placebo-controlled efficacy and safety of atomoxetine (ATX) for attention-deficit/hyperactivity disorder (ADHD) symptoms in children with autism spectrum disorders (ASD). Method: Children ages 5 to 15 with ASD and prominent ADHD symptoms were randomly assigned to order in a crossover of clinically titrated ATX and placebo, 6…
Descriptors: Hyperactivity, Autism, Drug Therapy, Attention Deficit Disorders
